Marconi Corp. PLC

Since redundancies in Europe are expensive and politically sensitive, companies have tended, where possible, to find other ways of cutting costs. The prolonged biotech winter is leaving many European

Genomic content providers like Incyte Genomics Inc. and Celera Genomics Group have packed up their databases and moved downstream into drug development. Despite their proximity to profitability,

UCL Ventures wasn't part of a grand plan on behalf of University College London to commercialize its research; much like the university's technology transfer department, it was created primarily in

Combining advanced image guidance and robotics to painlessly treat head and neck tumors with radiation, Accuray hopes the rest of the body will follow. by Stephen Levin Medical device development is n